vs
Astrana Health, Inc.（ASTH）与TSS, Inc.（TSSI）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是TSS, Inc.的15.6倍（$950.5M vs $60.9M）。TSS, Inc.净利率更高（20.0% vs 0.7%，领先19.3%）。Astrana Health, Inc.同比增速更快（42.9% vs 21.8%）。TSS, Inc.自由现金流更多（$15.8M vs $-6.0M）。过去两年TSS, Inc.的营收复合增速更高（95.8% vs 53.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
ASTH vs TSSI — 直观对比
营收规模更大
ASTH
是对方的15.6倍
$60.9M
营收增速更快
ASTH
高出21.1%
21.8%
净利率更高
TSSI
高出19.3%
0.7%
自由现金流更多
TSSI
多$21.7M
$-6.0M
两年增速更快
TSSI
近两年复合增速
53.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $60.9M |
| 净利润 | $6.6M | $12.2M |
| 毛利率 | — | 17.6% |
| 营业利润率 | 1.9% | 1.5% |
| 净利率 | 0.7% | 20.0% |
| 营收同比 | 42.9% | 21.8% |
| 净利润同比 | 184.4% | 535.7% |
| 每股收益（稀释后） | $0.12 | $0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHTSSI
| Q4 25 | $950.5M | $60.9M | ||
| Q3 25 | $956.0M | $41.9M | ||
| Q2 25 | $654.8M | $44.0M | ||
| Q1 25 | $620.4M | $99.0M | ||
| Q4 24 | $665.2M | $50.0M | ||
| Q3 24 | $478.7M | $70.1M | ||
| Q2 24 | $486.3M | $12.2M | ||
| Q1 24 | $404.4M | $15.9M |
净利润ASTHTSSI
| Q4 25 | $6.6M | $12.2M | ||
| Q3 25 | $373.0K | $-1.5M | ||
| Q2 25 | $9.4M | $1.5M | ||
| Q1 25 | $6.7M | $3.0M | ||
| Q4 24 | $-7.8M | $1.9M | ||
| Q3 24 | $16.1M | $2.6M | ||
| Q2 24 | $19.2M | $1.4M | ||
| Q1 24 | $14.8M | $15.0K |
毛利率ASTHTSSI
| Q4 25 | — | 17.6% | ||
| Q3 25 | — | 11.1% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 37.3% | ||
| Q1 24 | — | 17.1% |
营业利润率ASTHTSSI
| Q4 25 | 1.9% | 1.5% | ||
| Q3 25 | 2.0% | -2.2% | ||
| Q2 25 | 3.1% | 5.1% | ||
| Q1 25 | 3.3% | 4.2% | ||
| Q4 24 | 0.1% | 0.0% | ||
| Q3 24 | 5.9% | 5.4% | ||
| Q2 24 | 6.2% | 14.0% | ||
| Q1 24 | 7.5% | 1.6% |
净利率ASTHTSSI
| Q4 25 | 0.7% | 20.0% | ||
| Q3 25 | 0.0% | -3.6% | ||
| Q2 25 | 1.4% | 3.4% | ||
| Q1 25 | 1.1% | 3.0% | ||
| Q4 24 | -1.2% | 3.8% | ||
| Q3 24 | 3.4% | 3.8% | ||
| Q2 24 | 3.9% | 11.5% | ||
| Q1 24 | 3.7% | 0.1% |
每股收益（稀释后）ASTHTSSI
| Q4 25 | $0.12 | $0.44 | ||
| Q3 25 | $0.01 | $-0.06 | ||
| Q2 25 | $0.19 | $0.06 | ||
| Q1 25 | $0.14 | $0.12 | ||
| Q4 24 | $-0.14 | $0.08 | ||
| Q3 24 | $0.33 | $0.10 | ||
| Q2 24 | $0.40 | $0.06 | ||
| Q1 24 | $0.31 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $85.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $76.6M |
| 总资产 | $2.2B | $184.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHTSSI
| Q4 25 | $429.5M | $85.5M | ||
| Q3 25 | $463.4M | $70.7M | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | $23.2M | ||
| Q3 24 | $350.3M | $46.4M | ||
| Q2 24 | $327.7M | $8.3M | ||
| Q1 24 | $337.3M | $14.4M |
股东权益ASTHTSSI
| Q4 25 | $779.3M | $76.6M | ||
| Q3 25 | $775.5M | $63.4M | ||
| Q2 25 | $765.5M | $9.5M | ||
| Q1 25 | $745.4M | $9.4M | ||
| Q4 24 | $712.7M | $7.1M | ||
| Q3 24 | $704.6M | $7.7M | ||
| Q2 24 | $678.9M | $5.2M | ||
| Q1 24 | $653.5M | $3.7M |
总资产ASTHTSSI
| Q4 25 | $2.2B | $184.9M | ||
| Q3 25 | $2.2B | $165.4M | ||
| Q2 25 | $1.4B | $139.5M | ||
| Q1 25 | $1.3B | $113.5M | ||
| Q4 24 | $1.4B | $96.6M | ||
| Q3 24 | $1.3B | $67.3M | ||
| Q2 24 | $1.3B | $28.9M | ||
| Q1 24 | $1.2B | $26.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $16.3M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $15.8M |
| 自由现金流率自由现金流/营收 | -0.6% | 25.9% |
| 资本支出强度资本支出/营收 | 0.3% | 0.9% |
| 现金转化率经营现金流/净利润 | -0.44× | 1.34× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $2.1M |
8季度趋势，按日历期对齐
经营现金流ASTHTSSI
| Q4 25 | $-2.9M | $16.3M | ||
| Q3 25 | $10.0M | $-18.4M | ||
| Q2 25 | $90.9M | $16.3M | ||
| Q1 25 | $16.6M | $20.6M | ||
| Q4 24 | $-10.9M | $-21.6M | ||
| Q3 24 | $34.0M | $38.6M | ||
| Q2 24 | $23.2M | $-4.3M | ||
| Q1 24 | $6.0M | $2.6M |
自由现金流ASTHTSSI
| Q4 25 | $-6.0M | $15.8M | ||
| Q3 25 | $7.4M | $-24.9M | ||
| Q2 25 | $89.5M | $5.4M | ||
| Q1 25 | $13.6M | $5.8M | ||
| Q4 24 | $-13.5M | $-28.4M | ||
| Q3 24 | $31.7M | $38.6M | ||
| Q2 24 | $20.4M | $-6.0M | ||
| Q1 24 | $5.6M | $2.6M |
自由现金流率ASTHTSSI
| Q4 25 | -0.6% | 25.9% | ||
| Q3 25 | 0.8% | -59.3% | ||
| Q2 25 | 13.7% | 12.3% | ||
| Q1 25 | 2.2% | 5.8% | ||
| Q4 24 | -2.0% | -56.7% | ||
| Q3 24 | 6.6% | 55.1% | ||
| Q2 24 | 4.2% | -49.4% | ||
| Q1 24 | 1.4% | 16.4% |
资本支出强度ASTHTSSI
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.3% | 15.3% | ||
| Q2 25 | 0.2% | 24.8% | ||
| Q1 25 | 0.5% | 15.0% | ||
| Q4 24 | 0.4% | 13.4% | ||
| Q3 24 | 0.5% | 0.1% | ||
| Q2 24 | 0.6% | 13.8% | ||
| Q1 24 | 0.1% | 0.2% |
现金转化率ASTHTSSI
| Q4 25 | -0.44× | 1.34× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 11.02× | ||
| Q1 25 | 2.48× | 6.93× | ||
| Q4 24 | — | -11.32× | ||
| Q3 24 | 2.11× | 14.60× | ||
| Q2 24 | 1.21× | -3.09× | ||
| Q1 24 | 0.40× | 176.40× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
